Search Results 1141-1150 of 15364 for blueberry
Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to collect skin biopsies from patients who have known cases of chemotherapy induced peripheral neuropathy and analyze the samples ...
The purpose of this study is to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, ...
The Mayo Clinic Center for Regenerative Biotherapeutics works with the Human Cellular Therapy Laboratories to develop safe products for improved patient ...
The purpose of this study is to evaluate three different daratumumab dose schedules to treat participants who have Smoldering Multiple Myeloma. Participation ...
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14- ...
About this study. The purpose of this study is to determine if migraine patients engaged with the MICP will report improved migraine outcomes, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.